Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Lavin

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Lasers in Surgery and Medicine|March 10, 2022
Safety of a 1064-nm robotic laser system for noninvasive lipolysis of the flanksThomas Fiala, Philip Lavin
JAMA|April 1, 2024
Multitarget Stool RNA TestingThomas F Imperiale, Philip Lavin, David F Ransohoff
The American Journal of Sports Medicine|October 21, 2024
Subacromial Balloon Placement: Letter to the EditorNikhil N Verma, Zeeshan A Khan, Philip Lavin
Journal of the American College of Surgeons|September 28, 2010
Prospective randomized trial of accelerated re-epithelialization of skin graft donor sites using extracorporeal shock wave therapyChristian Ottoman, Bernd Hartmann, Wolfgang Schaden, et al.
Annals of Internal Medicine|April 7, 2020
Screening for Colorectal Cancer in Asymptomatic Average-Risk AdultsThomas F Imperiale, Steven H Itzkowitz, David F Ransohoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2017
Carboplatin and Etoposide With or Without Palifosfamide in Untreated Extensive-Stage Small-Cell Lung Cancer: A Multicenter, Adaptive, Randomized Phase III Study (MATISSE)Shadia I Jalal, Philip Lavin, Gregory Lo, et al.
Critical Care Medicine|January 5, 2011
A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trialDennis G Maki, Stephen R Ash, Roland K Winger, et al.
Infection Control and Hospital Epidemiology|March 6, 2020
Antiseptic efficacy of an innovative perioperative surgical skin preparation: A confirmatory FDA phase 3 analysisCharles E Edmiston, Philip Lavin, Maureen Spencer, et al.
Lipids in Health and Disease|November 13, 2020
Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemiaAdrian M Di Bisceglie, Gerald F Watts, Philip Lavin, et al.
International Journal of Bipolar Disorders|August 13, 2023
NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trialAndrew Nierenberg, Philip Lavin, Daniel C Javitt, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Lasers in Surgery and Medicine|March 10, 2022
Safety of a 1064-nm robotic laser system for noninvasive lipolysis of the flanksThomas Fiala, Philip Lavin
JAMA|April 1, 2024
Multitarget Stool RNA TestingThomas F Imperiale, Philip Lavin, David F Ransohoff
The American Journal of Sports Medicine|October 21, 2024
Subacromial Balloon Placement: Letter to the EditorNikhil N Verma, Zeeshan A Khan, Philip Lavin
Journal of the American College of Surgeons|September 28, 2010
Prospective randomized trial of accelerated re-epithelialization of skin graft donor sites using extracorporeal shock wave therapyChristian Ottoman, Bernd Hartmann, Wolfgang Schaden, et al.
Annals of Internal Medicine|April 7, 2020
Screening for Colorectal Cancer in Asymptomatic Average-Risk AdultsThomas F Imperiale, Steven H Itzkowitz, David F Ransohoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2017
Carboplatin and Etoposide With or Without Palifosfamide in Untreated Extensive-Stage Small-Cell Lung Cancer: A Multicenter, Adaptive, Randomized Phase III Study (MATISSE)Shadia I Jalal, Philip Lavin, Gregory Lo, et al.
Critical Care Medicine|January 5, 2011
A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trialDennis G Maki, Stephen R Ash, Roland K Winger, et al.
Infection Control and Hospital Epidemiology|March 6, 2020
Antiseptic efficacy of an innovative perioperative surgical skin preparation: A confirmatory FDA phase 3 analysisCharles E Edmiston, Philip Lavin, Maureen Spencer, et al.
Lipids in Health and Disease|November 13, 2020
Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemiaAdrian M Di Bisceglie, Gerald F Watts, Philip Lavin, et al.
International Journal of Bipolar Disorders|August 13, 2023
NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trialAndrew Nierenberg, Philip Lavin, Daniel C Javitt, et al.
Pageof 2